as mentioned in thestreet
How Will GlaxoSmithKline (GSK) Stock React to New HIV Drug Development?
How Will GlaxoSmithKline (GSK) Stock React to New HIV Drug Development?
not to mention 13wham
New clinical trial to prevent the spread of HIV
New clinical trial to prevent the spread of HIV
Rochester, N.Y. - Rochester has an HIV problem, but it could also become part of the solution.The community has the second highest HIV infection rate per capita in the state, outside of New York City.The Rochester Victory Alliance is conducting a clinical trial that aims to stop the spread of the virus in hopes of creating a vaccine.
let alone fortune
GlaxoSmithKline Is Working on New HIV
GlaxoSmithKline Is Working on New HIV
The prognosis for HIV/AIDS has made remarkable progress over the last two decades, transforming from a death sentence to a largely manageable condition.But GlaxoSmithKline gsk hopes to take it a step further by lopping off one-third of the drugs most patients are required to take.GSK CEO Andrew Witty says that the firm is aiming to get the three-drug cocktail regimen to down to just two different drugs, according to the Wall Street Journal.
No comments:
Post a Comment